ANALYSIS OF APOLIPOPROTEIN-B (APO-B) GENE IN ATHEROSCLEROSIS MICE GIVEN CURCUMINOID EXTRACT OF ZANTHORRIZA IN ORAL
Abstract
Keywords
Full Text:
PDFReferences
Deodhar, S.D., R. Sethi, R.C.Srimal. 1980. Preliminary study on antirheumatic activity of curcumin (Diferuloyl methane). J. Ind. Med. Res. 71:632-634.
Hansson, G.K. 2009. Atherosclerosis-an immune disease: the Atnitschove lecture 2007. Atheroscler, 202(1):2:10.
Kaplan, M., M. Aviram. 2001. Retention of oxidation LDL by extracellular matrix proteoglycans leads to Its uptake by macrophages an alternative approach to Study lipoprotein cellular uptake. J. Arterioscler Thromb Vasc Biol. 21:386-393.
Kiso, Y.,Y. Suzuki, N.Watanabe, Y.Osima, H. Hikino.1983. Antihepatotoxic principles of curcuma Longa rhizomes. J, Med. Plant. Res. 49:185-187.
Law, S. W., K. J.Lackner, A. V. Hospattankar, J. M.Anchors, A. Y. Sakaguchi, S. L.Naylor, H. B. Brewer, Jr. 1985. Human apolipoprotein B-100: cloning, analysis of liver mRNA, and assignment of the gene to chromosome 2. Proc. Nat. Acad. Sci. 82: 8340-8344.
Libby, P. 2002. Inflamation in atherosclerosis. Nature 42:868-874.
Mc Gill HC Jr. 1968. Fatty Streak in the Coronary arteries and aorta. Lab. Invest 10: 560.
M.J.McQueen, S. Hawken, X.Wang. 2008. Lipids, lipoproteins, and apolipoproteins as risk markers of myocardial infarction in 52 countries (the INTERHEART study): a case-control study". Lancet 372 (9634): 224–33.
J.M. Munro, R.S. Cotrans. 1988. The pathogenesis of atherosclerosis: atherogenesis and inflammation. Lab. Invest. 58:249-261.
J.L. Quiles, M. Dolores, C.L.Ramires-Tortosa, C.M. Aquilera, M. Battina, A. Gill, M.C. Ramires-Tortosa. 2002. Curcuma longa extract suplementation reduces oxidative stress and attenuates aortic fatty streak development in rabbits. Arteriolscler Thromb Vasc Biol. 22:1225-1231.
Rackley. C.E. 2007. Phathogenesis of Atherosclerosis. http://www.patiens.update.com/print.asp?print=true&file=chd/2109 [12 Juli 2009].
Rao, M.N.A. 1995. Antioxidant properties of curcumin. Proceeding of the International Symphosium on Curcumin Pharmacochemistry (ISCP), Yogyakarta Indonesia. Curcumin Pharmacochemistry. Yogyakarta.
Ross, R and J.A.Glomset. 1976. The pathogenesis of atherosclerosis. N. Eng.LJ. Med. 295: 369, 420.
Small, D.M. 1998. Progression and regression of atherosclerotic lesions. Insights from lipid physical biochemistry, Masachussets.
Sreejayan, N., M.N.A., Rao. 1997. Nitric oxid scavenging by curcuminoids. J. Phar. Pharmacols 49: 105 - 107.
Stary, H.C., A.B. Chandler, R.E.,Dnsmor, V.Fuster, S. Glagov, W. Insull, M.E. Rosenfeld, C.J.Schwart, W.D. Wagner and R.W. Wisller. 1990. A definition of advanced types of atherosclerotic Lesions and histological classification of atherosclerosis. Arteriolscler Thromb Vasc. Biol. 15:1512-1531.
Steinberg, D. 1993. Vitamin E for a healthy heart. New Eng. J. Med. 31:33- 58.
Tabas, I., K.J.Williams, J. Borén. 2007. Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications. Circulation (journal) 116 (16): 1832–1844. doi:10.1161/circulationaha.106 .
Tonnessen, H.H., H.D.Vries, J. Karlse, G.B. Henenggouwen. 1987. Studies of curcumin and curcuminoid in investigation of the photobiological activity of curcumin using bacterial indication system. J. Pharm. Sci. 76: 371-373.
DOI: https://doi.org/10.21157/j.ked.hewan.v13i2.10219
Article Metrics
Abstract view : 0 timesPDF - 0 times
Refbacks
- There are currently no refbacks.
Indexed by:
p-ISSN: 1978-225X | e-ISSN: 2502-5600 | Copyright© 2007-2021